FMEBX Performance — American Funds Emerging Markets Bond Fund, Class 529-F-3
Data updated: 2026-08-27
FMEBX returned +2.80% year to date and +9.03% over one year to Jun 2026. Annualised returns are +8.43% over 3 years and +3.42% over 5 years. The fund trailed its Emerging Markets Bond category average: $100 invested three years ago grew to $127, against $130 for the category, and to $109 over one year, against $110. Volatility over the past three years was 6.93% a year. In the 12 months to Jun 2026 the fund took in a net $3.5B, and assets reached $6.71B.
FMEBX Growth of $100
What $100 invested in American Funds Emerging Markets Bond Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Emerging Markets Bond category average over the same months.
| Period | FMEBX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $109 | $110 |
| 3 years (Jul 2023 – Jun 2026) | $127 | $130 |
| 5 years (Jul 2021 – Jun 2026) | $118 | $116 |
| Since data start (Oct 2020 – Jun 2026) | $126 | $122 |
FMEBX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +2.80% |
| 1 year | +9.03% |
| 3 years (annualised) | +8.43% |
| 5 years (annualised) | +3.42% |
FMEBX Annual Returns
Calendar-year total returns of American Funds Emerging Markets Bond Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +2.80% |
| 2025 | +16.25% |
| 2024 | +0.60% |
| 2023 | +13.76% |
| 2022 | −12.02% |
| 2021 | −3.66% |
| 2020 (Oct–Dec) | +8.97% |
FMEBX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.4% | +1.3% | −3.9% | +2.6% | +0.8% | +0.8% | — | — | — | — | — | — |
| 2025 | +2.0% | +1.0% | +0.6% | +1.3% | +1.3% | +3.0% | −0.1% | +2.2% | +1.4% | +0.8% | +0.9% | +0.8% |
| 2024 | −1.0% | +0.2% | +1.1% | −2.2% | +1.8% | −0.4% | +1.8% | +2.3% | +2.6% | −3.2% | +0.1% | −2.2% |
| 2023 | +4.5% | −4.1% | +2.7% | +0.1% | −0.3% | +4.6% | +2.5% | −2.2% | −2.9% | −0.5% | +5.2% | +4.1% |
| 2022 | −1.1% | −6.3% | −1.9% | −5.3% | +1.2% | −5.4% | +2.6% | +0.3% | −5.8% | +1.1% | +7.8% | +1.2% |
| 2021 | −1.2% | −2.0% | −2.2% | +1.9% | +1.8% | −0.2% | 0.0% | +1.4% | −2.0% | −0.3% | −2.2% | +1.5% |
| 2020 | — | — | — | — | — | — | — | — | — | 0.0% | +5.5% | +3.3% |
FMEBX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 6.93%
- 3-year Sharpe ratio: 0.57 (vs 4.5% risk-free rate)
- Best month: +5.17% (Nov 2023)
- Worst month: −3.92% (Mar 2026)
FMEBX Fund Flows
Monthly money in and out of American Funds Emerging Markets Bond Fund, from SEC Form N-PORT.
- 12-month net flow: $3.5B
- 12-month gross sales (incl. reinvestments): $3.9B
- Sales ÷ redemptions: 8.26×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $196.0M | $39.6M | $156.3M |
| May 2026 | $173.0M | $29.7M | $143.3M |
| Apr 2026 | $2.5B | $40.4M | $2.4B |
| Mar 2026 | $91.3M | $86.6M | $4.8M |
| Feb 2026 | $75.2M | $20.4M | $54.8M |
| Jan 2026 | $393.8M | $85.4M | $308.3M |
| Dec 2025 | $90.0M | $38.0M | $52.1M |
| Nov 2025 | $62.6M | $45.9M | $16.7M |
| Oct 2025 | $82.7M | $30.3M | $52.4M |
| Sep 2025 | $83.1M | $19.0M | $64.2M |
| Aug 2025 | $98.0M | $24.4M | $73.6M |
| Jul 2025 | $125.0M | $18.4M | $106.7M |
FMEBX Assets Under Management
Net assets of American Funds Emerging Markets Bond Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $6.71B |
| 2026-03-31 | $3.88B |
| 2025-12-31 | $3.63B |
| 2025-09-30 | $3.48B |
| 2025-06-30 | $3.17B |
| 2025-03-31 | $2.91B |
| 2024-12-31 | $2.73B |
| 2024-09-30 | $2.54B |
| 2024-06-30 | $2.32B |
| 2024-03-31 | $1.39B |
| 2023-12-31 | $1.09B |
| 2023-09-30 | $984.15M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.